Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

538964

MERCURYLAB

img img img img
No Data Available

Mercury Laboratories Limited Share Price Update

As of the latest trading session, Mercury Laboratories Limited share price is currently at ₹ 783, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 783.00 and ₹ 783.00. Over the past year, Mercury Laboratories Limited has achieved a return of -12.02 %. In the last month alone, the return has been -4.17 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Mercury Laboratories Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    94.00

  • P/E Ratio (TTM)

    19.12

  • Beta

    0.49

  • Book Value / share

    464.65

  • Return on equity

    6.01%

  • EPS (TTM)

    40.95

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    1.64

info icon alternate text

Mercury Laboratories Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 19.01
Operating Expense 17.86
Net Profit 1.64
Net Profit Margin (%) 8.62
Earnings Per Share (EPS) 13.69
EBITDA 2.90
Effective Tax Rate (%) 14.58
Particulars JUN 2025 (Values in Cr)
Revenue 18.14
Operating Expense 16.77
Net Profit 0.97
Net Profit Margin (%) 5.34
Earnings Per Share (EPS) 8.06
EBITDA 2.54
Effective Tax Rate (%) 37.41
Particulars MAR 2025 (Values in Cr)
Revenue 20.66
Operating Expense 19.40
Net Profit 1.11
Net Profit Margin (%) 5.37
Earnings Per Share (EPS) 9.25
EBITDA 2.31
Effective Tax Rate (%) 23.44
Particulars DEC 2024 (Values in Cr)
Revenue 19.57
Operating Expense 18.45
Net Profit 1.19
Net Profit Margin (%) 6.08
Earnings Per Share (EPS) 9.94
EBITDA 2.51
Effective Tax Rate (%) 27.43
Particulars SEP 2024 (Values in Cr)
Revenue 18.19
Operating Expense 17.75
Net Profit 0.50
Net Profit Margin (%) 2.74
Earnings Per Share (EPS) 4.17
EBITDA 1.51
Effective Tax Rate (%) 23.07
Particulars MAR 2025 (Values in Cr)
Revenue 75.10
Operating Expense 71.50
Net Profit 3.14
Net Profit Margin (%) 4.18
Earnings Per Share (EPS) 26.21
EBITDA 8.09
Effective Tax Rate (%) 32.61
Particulars MAR 2024 (Values in Cr)
Revenue 75.56
Operating Expense 69.72
Net Profit 5.65
Net Profit Margin (%) 7.47
Earnings Per Share (EPS) 47.12
EBITDA 10.12
Effective Tax Rate (%) 18.35
Particulars MAR 2023 (Values in Cr)
Revenue 75.33
Operating Expense 69.61
Net Profit 5.58
Net Profit Margin (%) 7.40
Earnings Per Share (EPS) 46.49
EBITDA 10.28
Effective Tax Rate (%) 25.13
Particulars MAR 2022 (Values in Cr)
Revenue 57.92
Operating Expense 53.84
Net Profit 3.56
Net Profit Margin (%) 6.14
Earnings Per Share (EPS) 29.68
EBITDA 7.93
Effective Tax Rate (%) 29.22
Particulars MAR 2021 (Values in Cr)
Revenue 68.60
Operating Expense 61.57
Net Profit 5.34
Net Profit Margin (%) 7.78
Earnings Per Share (EPS) 44.48
EBITDA 10.47
Effective Tax Rate (%) 32.49
Particulars MAR 2025 (Values in Cr)
Book Value / Share 446.41
ROE % 6.01
ROCE % 8.98
Total Debt to Total Equity 0.11
EBITDA Margin 10.77
Particulars MAR 2024 (Values in Cr)
Book Value / Share 423.65
ROE % 11.71
ROCE % 13.50
Total Debt to Total Equity 0.12
EBITDA Margin 13.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 380.24
ROE % 12.99
ROCE % 15.78
Total Debt to Total Equity 0.14
EBITDA Margin 13.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 335.89
ROE % 9.22
ROCE % 11.81
Total Debt to Total Equity 0.17
EBITDA Margin 13.71
Particulars MAR 2021 (Values in Cr)
Book Value / Share 307.45
ROE % 15.51
ROCE % 19.97
Total Debt to Total Equity 0.21
EBITDA Margin 15.26
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.19
Total Assets 74.23
Total Liabilities 74.23
Total Equity 53.56
Share Outstanding 1200000
Price to Book Ratio 1.83
Return on Assets (%) 4.23
Return on Capital (%) 5.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.22
Total Assets 67.95
Total Liabilities 67.95
Total Equity 50.83
Share Outstanding 1200000
Price to Book Ratio 1.96
Return on Assets (%) 8.32
Return on Capital (%) 10.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.31
Total Assets 64.16
Total Liabilities 64.16
Total Equity 45.62
Share Outstanding 1200000
Price to Book Ratio 1.54
Return on Assets (%) 8.69
Return on Capital (%) 10.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.93
Total Assets 62.43
Total Liabilities 62.43
Total Equity 40.30
Share Outstanding 1200000
Price to Book Ratio 1.44
Return on Assets (%) 5.70
Return on Capital (%) 7.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 65.37
Total Liabilities 65.37
Total Equity 36.89
Share Outstanding 1200000
Price to Book Ratio 2.09
Return on Assets (%) 8.16
Return on Capital (%) 12.37
Particulars MAR 2025 (Values in Cr)
Net Income 4.66
Cash from Operations 6.39
Cash from Investing -9.03
Cash from Financing -0.99
Net change in Cash -6.03
Free Cash Flow 15.43
Particulars MAR 2024 (Values in Cr)
Net Income 6.92
Cash from Operations 9.48
Cash from Investing -6.27
Cash from Financing -1.04
Net change in Cash 0.91
Free Cash Flow 15.75
Particulars MAR 2023 (Values in Cr)
Net Income 7.44
Cash from Operations 3.55
Cash from Investing -1.05
Cash from Financing -1.01
Net change in Cash 0.38
Free Cash Flow 4.61
Particulars MAR 2022 (Values in Cr)
Net Income 5.03
Cash from Operations 7.10
Cash from Investing -1.89
Cash from Financing -1.23
Net change in Cash 2.06
Free Cash Flow 9.01
Particulars MAR 2021 (Values in Cr)
Net Income 7.90
Cash from Operations 9.58
Cash from Investing -4.61
Cash from Financing -1.23
Net change in Cash 2.35
Free Cash Flow 14.20
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.07 12.78 1.35 199.78 24.01 / 53.83
BLISS GVS PHARMA LTD 154.90 14.95 1.44 1638.67 105.05 / 195.85
CIPLA LTD 1371.55 20.36 3.36 110789.86 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 324.95 8.54 2.44 956.36 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2379.85 42.29 23.60 40316.10 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.07 21.20 3.63 199.78 24.01 / 53.83
AMRUTAJAN HEALTH LTD 625.60 31.90 5.28 1808.65 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8347.05 90.27 26.11 20867.63 6501.60 / 10653.05
BLISS GVS PHARMA LTD 154.90 20.90 1.48 1638.67 105.05 / 195.85

Mercury Laboratories Limited shareholding pattern

Holding

26.34%
73.65%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Mercury Laboratories Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
783.00 0.00 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 796.60
  • 26 Days 820.50
  • 10 Days 805.50
  • 50 Days 832.30
  • 12 Days 808.10
  • 100 Days 842.80
  • 20 Days 816.00
  • 200 Days 856.10
783.00 PIVOT

First Support

783.00

First Resistance

783.00

Second Support

783.00

Second Resistance

783.00

Third Support

783.00

Third Resistance

783.00

RSI

36.95

ADX

9.29

MACD

-12.47

Williams % R

-100.00

Commodity Channel Index (CCI)

-207.58

Date

2026-01-21

Week

75.00

Same Day

8.00

Month

66.00

1 Year

0.49

3 Year

0.48

Over 1 Month

-4.17%

down

Over 1 Year

-12.02%

down

Over 3 Months

-11.73%

down

Over 3 Years

-0.68%

down

Over 6 Months

-9.17%

down

Over 5 Years

3.47%

down

Mercury Laboratories Limited Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
06 Aug 2025 3.5 Final 06 Aug 2025 Equity shares
20 Sep 2024 3.5 Final 21 Sep 2024 Equity shares
20 Sep 2023 3.5 Final 21 Sep 2023 Equity shares
19 Sep 2022 3.5 Final 21 Sep 2022 Equity shares
20 Sep 2021 2.0 Final 22 Sep 2021 Equity shares
22 Feb 2021 1.5 Interim 23 Feb 2021 Equity shares
21 Sep 2020 2.0 Final 23 Sep 2020 Equity shares
19 Sep 2019 1.5 Final 23 Sep 2019 Equity shares
31 Aug 2018 1.5 Final 04 Sep 2018 Equity shares
15 Sep 2017 1.5 Final 19 Sep 2017 Equity shares
15 Sep 2016 1.5 Final 19 Sep 2016 Equity shares
16 Sep 2015 1.5 Final 19 Sep 2015 Equity shares

Top Gainers

Mercury Laboratories Limited Share Price

Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, it converted into Private Limited Company & incorporated in February, 1982. Later, it converted into Limited Company in 1992 in Maharashtra. The Company has obtained ISO 9001:2008 registrations. It is engaged into the manufacturing and export of wide range of Pharmaceutical items. The Company products have been in Gynae and Pediatrics Segment. It is mainly dedicated to Mother & Child Healthcare.

Two new products launched in Ergacap Division in 2012-13. The Company introduced new drugs such as Teclobet, Tanolite, Clinzit, Clinzita-A, Levotryl Tablet, Levotryl-M Tablet, Levotryl Syrup, THA-4, THA-8, Pyloryl, Pangs At, Feveryl Drops, Feveryl Suspension in its Mother Child Care specialized segment. It further established Institutional Business with Govt. Institutions, Semi Government and Hospitals & Clinics in 2014-15.

The Company launched new world class GMP facility for all its liquids and tablets conforming requirement of WHO in 2015-16. It also has increased the manufacturing capacity for tablets and liquids in 2023-24.

Parent organization Indian Private
NSE symbol [-]
Founded 1982
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Mercury Laboratories Ltd?

Answer Field

Mercury Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 783.00 as on Jan 23 2026 11:23 AM.

What is the Market Cap of Mercury Laboratories Ltd Share?

Answer Field

The market cap of Mercury Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 94.00 as on Jan 23 2026 11:23 AM.

What is the 52 Week High and Low of Mercury Laboratories Ltd?

Answer Field

The 52 Week High and Low of Mercury Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 976.00 and ₹ 736.00.

What is 1 year return for Mercury Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -12.02%.

What is the P/E Ratio of Mercury Laboratories Ltd Share?

Answer Field

As on Jan 23 2026 11:23 AM the price-to-earnings (PE) ratio for Mercury Laboratories Ltd share is 19.12.

What is the PB ratio of Mercury Laboratories Ltd Share?

Answer Field

As on Jan 23 2026 11:23 AM, the price-to-book (PB) ratio for Mercury Laboratories Ltd share is 464.65.

How to Buy Mercury Laboratories Ltd Share?

Answer Field

You can trade in Mercury Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mercury Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Mercury Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mercury Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59